ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
+4.9%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$103M
AUM Growth
+$103M
(-12%)
Cap. Flow
-$5.8M
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
67.36%
Holding
32
New
2
Increased
10
Reduced
13
Closed
6
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$9.99M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$8.83M |
| 3 |
Soleno Therapeutics
SLNO
|
$2.34M |
| 4 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$2.34M |
| 5 |
Praxis Precision Medicines
PRAX
|
$1.92M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$12.3M |
| 2 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$3.5M |
| 3 |
Jasper Therapeutics
JSPR
|
$2.62M |
| 4 |
EyePoint Pharmaceuticals
EYPT
|
$2.59M |
| 5 |
89bio
ETNB
|
$2.49M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
| $12.4M | 11.18% | 281,139 +226,447 | +414% | +$9.99M |
|
|
VRNA
2
Verona Pharma
VRNA
$9.16B
| $8.83M | 7.96% | +139,067 | New | +$8.83M |
|
|
3
Soleno Therapeutics
SLNO
$3.6B
| $8.61M | 7.76% | 120,449 +32,820 | +37% | +$2.34M |
|
4
Axsome Therapeutics
AXSM
$6.05B
| $8.41M | 7.58% | 72,113 +5,452 | +8% | +$636K |
|
5
Tarsus Pharmaceuticals
TARS
$2.47B
| $6.57M | 5.92% | 127,932 -45,212 | -26% | -$2.32M |
|
|
BPMC
6
DELISTED
Blueprint Medicines
BPMC
| $6.57M | 5.92% | 74,192 +18,300 | +33% | +$1.62M |
|
7
Insmed
INSM
$28.8B
| $6.49M | 5.85% | 85,110 -29,250 | -26% | -$2.23M |
|
8
Trevi Therapeutics
TRVI
$883M
| $4.32M | 3.89% | 686,219 -95,270 | -12% | -$599K |
|
|
9
Praxis Precision Medicines
PRAX
$958M
| $3.62M | 3.26% | 95,582 +50,600 | +112% | +$1.92M |
|
|
CNTA
10
Centessa Pharmaceuticals
CNTA
$2.25B
| $3.5M | 3.15% | 243,086 -1,452 | -0.6% | -$20.9K |
|
11
Enliven Therapeutics
ELVN
$1.2B
| $3.34M | 3.01% | 169,774 +28,064 | +20% | +$552K |
|
12
Merus
MRUS
$4.98B
| $3.28M | 2.96% | 77,896 -38,900 | -33% | -$1.64M |
|
13
Geron
GERN
$893M
| $3.27M | 2.95% | 2,056,637 +981,813 | +91% | +$1.56M |
|
14
CG Oncology
CGON
$2.04B
| $3.24M | 2.92% | 132,298 -41,750 | -24% | -$1.02M |
|
|
ATYR
15
aTyr Pharma
ATYR
$527M
| $2.35M | 2.12% | 777,020 +77,290 | +11% | +$233K |
|
|
TECX
16
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $2.34M | 2.11% | +132,222 | New | +$2.34M |
|
17
Xenon Pharmaceuticals
XENE
$2.98B
| $2.34M | 2.11% | 69,603 -59,688 | -46% | -$2M |
|
18
MindMed
MNMD
$676M
| $2.28M | 2.06% | 390,143 +59,868 | +18% | +$350K |
|
19
Edgewise Therapeutics
EWTX
$1.51B
| $2.26M | 2.04% | 102,650 +19,474 | +23% | +$428K |
|
20
Janux Therapeutics
JANX
$1.37B
| $2.19M | 1.98% | 81,292 -9,000 | -10% | -$243K |
|
21
Dianthus Therapeutics
DNTH
$759M
| $1.46M | 1.32% | 80,584 -25,850 | -24% | -$469K |
|
|
WHWK
22
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $1.46M | 1.31% | 817,939 | – | – |
|
23
Korro Bio
KRRO
$217M
| $1.04M | 0.94% | 59,723 -10,955 | -15% | -$191K |
|
24
ProMIS Neurosciences
PMN
$28M
| $1.03M | 0.93% | 1,484,699 -107,906 | -7% | -$75K |
|
25
Tyra Biosciences
TYRA
$675M
| $997K | 0.9% | 107,244 -67,819 | -39% | -$631K |
|